Skip to main content

Loading market data...

CHE

Chemed Corporation

NYSE • United states

$516.07

+$7.78

(+1.53%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Chemed Corporation (CHE)

Unavailable

Quotes may be delayed

$6.75B

Market Cap

113,832

Volume

673.1

P/E Ratio

0.49%

Div Yield

Chemed Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: SUITE 2600, CINCINNATI, OH
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

12 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Chemed Corporation.

31 Jul 2026

Chemed Corporation filed Form 10-Q

Chemed Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

28 Jul 2026

Chemed Corporation reported Operating or financial results

Chemed Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

19 May 2026

Chemed Corporation reported Shareholder voting results

Chemed Corporation filed an 8-K covering shareholder voting results.

29 Apr 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Chemed Corporation.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$40.22M

Total assets (USD)$1.58B

Total liabilities (USD)$749.08M

Shareholders' equity (USD)$830.51M

Long-term debt (USD)$140.00M

Debt due within a year (USD)$5.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$673.25M	$89.20M	$67.70M	$5.13	10-Q · 31 Jul 2026
Q1 2026	$657.51M	$84.58M	$66.30M	$4.84	10-Q · 28 Apr 2026
Q4 2025	$639.34M	$100.65M	−$188.22M	Unavailable	10-K · 27 Feb 2026
Q3 2025	$624.90M	$74.75M	$64.24M	$4.46	10-Q · 31 Oct 2025
Q2 2025	$618.80M	$68.08M	$52.49M	$3.57	10-Q · 31 Jul 2025
Q1 2025	$646.94M	$94.76M	$71.76M	$4.86	10-Q · 28 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $584.50

13.3% upside potential

📈

Strong Buy

Unavailable

👍

Buy

2

⏸️

Hold

2

📉

Sell

0

4 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 21:49 UTC Targets range 548.00–650.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

30

Sep 2026

LEE SPENCER S

executive vice president

Option exercise

$445.35 per share

12,099 shares

30

Sep 2026

LEE SPENCER S

executive vice president

Tax withholding

$508.93 per share

11,160 shares

28

Sep 2026

MCNAMARA KEVIN J

Director, president and CEO

Open-market sale

$513.45 per share

2,000 shares

28

Sep 2026

HUTTON THOMAS C

Director, vice president

Option exercise

$445.35 per share

4,629 shares

28

Sep 2026

HUTTON THOMAS C

Director, vice president

Tax withholding

$506.65 per share

4,270 shares

18

Sep 2026

MCNAMARA KEVIN J

Director, president and CEO

Open-market sale

$501.40 per share

2,000 shares

21

Aug 2026

LEE SPENCER S

executive vice president

Open-market sale

$541.04 per share

1,000 shares

21

Aug 2026

MCNAMARA KEVIN J

Director, president and CEO

Open-market sale

$541.16 per share

2,000 shares

10

Aug 2026

Judkins Brian C

VP and Chief Legal Officer

Option exercise

$445.35 per share

6,786 shares

10

Aug 2026

Judkins Brian C

VP and Chief Legal Officer

Tax withholding

$548.96 per share

5,878 shares

Top Shareholders

Blackrock, Inc.

1,484,282 shares

11.042% change

6/30/2026

Vanguard Group Inc

1,472,254 shares

-4.305% change

12/31/2025

Aqr Capital Management Llc

972,474 shares

133.986% change

6/30/2026

Vanguard Portfolio Management Llc

787,068 shares

-3.51% change

6/30/2026

Vanguard Capital Management Llc

604,420 shares

-4.976% change

6/30/2026

Acadian Asset Management Llc

453,238 shares

47.689% change

6/30/2026

State Street Corp

444,716 shares

-3.777% change

6/30/2026

Geode Capital Management, Llc

413,942 shares

0.705% change

6/30/2026

Jpmorgan Chase & Co

403,395 shares

-19.48% change

6/30/2026

Boston Partners

280,684 shares

New% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 21:49 UTC· 1 day ago

Research coverage and investment tools

Chemed Corporation (CHE) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical/Nursing Services). Its last price was US$516.07 on 20 Oct 2026. That is 79% of the way from its 52-week low of US$365.21 to its 52-week high of US$557.00. It paid US$2.50 a share in dividends over the last 12 months, a dividend yield of 0.49%. The latest ex-dividend date on file is 17 Aug 2026. Its market capitalisation was US$6.75 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$673.25M	$89.20M	$67.70M	$5.13	—	13.2%	$69.29M	10-Q · 31 Jul 2026 (opens in a new tab)
Q1 2026	$657.51M	$84.58M	$66.30M	$4.84	—	12.9%	$71.10M	10-Q · 28 Apr 2026 (opens in a new tab)
Q4 2025	$639.34M	$100.65M	−$188.22M	Unavailable	—	15.7%	$117.19M	10-K · 27 Feb 2026 (opens in a new tab)
Q3 2025	$624.90M	$74.75M	$64.24M	$4.46	—	12.0%	$66.03M	10-Q · 31 Oct 2025 (opens in a new tab)
Q2 2025	$618.80M	$68.08M	$52.49M	$3.57	—	11.0%	$122.80M	10-Q · 31 Jul 2025 (opens in a new tab)
Q1 2025	$646.94M	$94.76M	$71.76M	$4.86	—	14.6%	$19.46M	10-Q · 28 Apr 2025 (opens in a new tab)

Cash and equivalents: $40.22M
Total assets: $1.58B
Total liabilities: $749.08M
Shareholders' equity: $830.51M
Long-term debt: $140.00M
Debt due within a year: $5.00M

SCHEDULE 13G · 12 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Chemed Corporation.
10-Q · 31 Jul 2026

Chemed Corporation filed Form 10-Q (opens in a new tab)

Chemed Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 28 Jul 2026

Chemed Corporation reported Operating or financial results (opens in a new tab)

Chemed Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 19 May 2026

Chemed Corporation reported Shareholder voting results (opens in a new tab)

Chemed Corporation filed an 8-K covering shareholder voting results.
SCHEDULE 13G · 29 Apr 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Chemed Corporation.

Insider	Date	Transaction	Shares	Average price	Filing
LEE SPENCER S executive vice president	30 Sep 2026	Option exercise (M)	+12,099	$445.35	Form 4 (opens in a new tab)
LEE SPENCER S executive vice president	30 Sep 2026	Tax withholding (F)	−11,160	$508.93	Form 4 (opens in a new tab)
MCNAMARA KEVIN J Director, president and CEO	28 Sep 2026	Open-market sale (S)	−2,000	$513.45	Form 4 (opens in a new tab)
HUTTON THOMAS C Director, vice president	28 Sep 2026	Option exercise (M)	+4,629	$445.35	Form 4 (opens in a new tab)
HUTTON THOMAS C Director, vice president	28 Sep 2026	Tax withholding (F)	−4,270	$506.65	Form 4 (opens in a new tab)
MCNAMARA KEVIN J Director, president and CEO	18 Sep 2026	Open-market sale (S)	−2,000	$501.40	Form 4 (opens in a new tab)
LEE SPENCER S executive vice president	21 Aug 2026	Open-market sale (S)	−1,000	$541.04	Form 4 (opens in a new tab)
MCNAMARA KEVIN J Director, president and CEO	21 Aug 2026	Open-market sale (S)	−2,000	$541.16	Form 4 (opens in a new tab)
Judkins Brian C VP and Chief Legal Officer	10 Aug 2026	Option exercise (M)	+6,786	$445.35	Form 4 (opens in a new tab)
Judkins Brian C VP and Chief Legal Officer	10 Aug 2026	Tax withholding (F)	−5,878	$548.96	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	1,484,282	11.042%
Vanguard Group Inc	12/31/2025	1,472,254	-4.305%
Aqr Capital Management Llc	6/30/2026	972,474	133.986%
Vanguard Portfolio Management Llc	6/30/2026	787,068	-3.51%
Vanguard Capital Management Llc	6/30/2026	604,420	-4.976%
Acadian Asset Management Llc	6/30/2026	453,238	47.689%
State Street Corp	6/30/2026	444,716	-3.777%
Geode Capital Management, Llc	6/30/2026	413,942	0.705%
Jpmorgan Chase & Co	6/30/2026	403,395	-19.48%
Boston Partners	6/30/2026	280,684	New

Previous close: 508.29 USD
Day range: 508.10 – 519.27 USD
52-week range: 365.21 – 557.00 USD
Volume: 113,832
Market cap: $6.75B
Average volume: 83,566
P/E ratio: 673.1
EPS (FY 2025, diluted): 18.34 USD
Dividends (last 12 months): 2.50 USD
Dividend yield: 0.49%
Ex-dividend date: 17 Aug 2026
Shares outstanding: 13.07M
Beta (5Y monthly): 0.51

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:39 UTC· 1 hour ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:39 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for CHE yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.